GH Filing
4Filing Date: Jun 30, 2026

Guardant Health, Inc. (GH) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001753159-26-000014open_in_new
Total Value$40.38M
Trades10
Insiders1

Transaction Details

Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Sell · Dispose
Common Stock
Shares-40
Price$153.00
Total Value$6.1K
Shares Owned After1.88M
Transaction DateJun 29, 2026
10b5-1
Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Sell · Dispose
Common Stock
Shares-70.51K
Price$151.47
Total Value$10.68M
Shares Owned After1.93M
Transaction DateJun 29, 2026
10b5-1
Footnotes ▸

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.00 to $151.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Sell · Dispose
Common Stock
Shares-46.66K
Price$152.20
Total Value$7.10M
Shares Owned After1.88M
Transaction DateJun 29, 2026
10b5-1
Footnotes ▸

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $152.00 to $152.68. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Exercise · Acquire
Common Stock
Shares+143.03K
Price$4.18
Total Value$597.9K
Shares Owned After2.02M
Transaction DateJun 29, 2026
10b5-1
Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Sell · Dispose
Common Stock
Shares-25.81K
Price$150.53
Total Value$3.89M
Shares Owned After2.00M
Transaction DateJun 29, 2026
10b5-1
Footnotes ▸

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Talasaz AmirAli
Co-Chief Executive Officer, Director·Direct
Exercise · Dispose
Stock Option (Right to Buy)Derivative
Shares-143.03K
Price$0.00
Total Value$0
Shares Owned After29.00K
Transaction DateJun 29, 2026
ExpiresJul 14, 2027
10b5-1
Footnotes ▸

The stock option vested in equal monthly installments over 48 months commencing on April 23, 2017.

Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Exercise · Acquire
Common Stock
Shares+111.80K
Price$4.18
Total Value$467.3K
Shares Owned After2.00M
Transaction DateJun 26, 2026
10b5-1
Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Sell · Dispose
Common Stock
Shares-52.94K
Price$151.16
Total Value$8.00M
Shares Owned After1.88M
Transaction DateJun 26, 2026
10b5-1
Footnotes ▸

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.00 to $151.79. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Talasaz AmirAli
Co-Chief Executive Officer, Director·Direct
Exercise · Dispose
Stock Option (Right to Buy)Derivative
Shares-111.80K
Price$0.00
Total Value$0
Shares Owned After172.03K
Transaction DateJun 26, 2026
ExpiresJul 14, 2027
10b5-1
Footnotes ▸

The stock option vested in equal monthly installments over 48 months commencing on April 23, 2017.

Talasaz AmirAli
Co-Chief Executive Officer, Director·Indirect · Shares held by Talasaz and Eskandari 2017 Family Trust
Sell · Dispose
Common Stock
Shares-64.04K
Price$150.49
Total Value$9.64M
Shares Owned After1.93M
Transaction DateJun 26, 2026
10b5-1
Footnotes ▸

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Post-Transaction Holdings

Talasaz AmirAli
SecuritySharesChange
Common Stock1.88M-5.17K (-0.27%)
Stock Option (Right to Buy)29.00K-254.83K (-89.78%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-06-26 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: Guardant Health, Inc. (GH) CIK: 0001576280 --- Reporting Owner --- Name: Talasaz AmirAli CIK: 0001753159 Role: Director, Officer (Co-Chief Executive Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-06-26 | Code: M (Exercise of derivative) Shares: +111,804 | Price: $4.18 Total Value: $467,340.72 Shares Owned After: 1,998,308 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust [Transaction #2] Security: Common Stock Date: 2026-06-26 | Code: S (Open market sale) Shares: -64,037 | Price: $150.49 Total Value: $9,636,838.48 Shares Owned After: 1,934,271 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust Footnotes: [F1] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. [Transaction #3] Security: Common Stock Date: 2026-06-26 | Code: S (Open market sale) Shares: -52,935 | Price: $151.16 Total Value: $8,001,628.13 Shares Owned After: 1,881,336 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust Footnotes: [F2] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.00 to $151.79. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. [Transaction #4] Security: Common Stock Date: 2026-06-29 | Code: M (Exercise of derivative) Shares: +143,028 | Price: $4.18 Total Value: $597,857.04 Shares Owned After: 2,024,364 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust [Transaction #5] Security: Common Stock Date: 2026-06-29 | Code: S (Open market sale) Shares: -25,812 | Price: $150.53 Total Value: $3,885,433.90 Shares Owned After: 1,998,552 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust Footnotes: [F1] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. [Transaction #6] Security: Common Stock Date: 2026-06-29 | Code: S (Open market sale) Shares: -70,513 | Price: $151.47 Total Value: $10,680,315.01 Shares Owned After: 1,928,039 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust Footnotes: [F3] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.00 to $151.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. [Transaction #7] Security: Common Stock Date: 2026-06-29 | Code: S (Open market sale) Shares: -46,663 | Price: $152.20 Total Value: $7,102,318.58 Shares Owned After: 1,881,376 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust Footnotes: [F4] Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $152.00 to $152.68. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. [Transaction #8] Security: Common Stock Date: 2026-06-29 | Code: S (Open market sale) Shares: -40 | Price: $153.00 Total Value: $6,120.00 Shares Owned After: 1,881,336 | Ownership: I (Indirect) | Nature: Shares held by Talasaz and Eskandari 2017 Family Trust --- Derivative Transactions --- [Transaction #1] Security: Stock Option (Right to Buy) Date: 2026-06-26 | Code: M (Exercise of derivative) Shares: -111,804 | Price: $0.00 Exercisable: N/A | Expires: 2027-07-14 Shares Owned After: 172,025 | Ownership: D (Direct) Footnotes: [F5] The stock option vested in equal monthly installments over 48 months commencing on April 23, 2017. [Transaction #2] Security: Stock Option (Right to Buy) Date: 2026-06-29 | Code: M (Exercise of derivative) Shares: -143,028 | Price: $0.00 Exercisable: N/A | Expires: 2027-07-14 Shares Owned After: 28,997 | Ownership: D (Direct) Footnotes: [F5] The stock option vested in equal monthly installments over 48 months commencing on April 23, 2017. --- Footnotes (Complete Index) --- F1: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. F2: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.00 to $151.79. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. F3: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.00 to $151.99. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. F4: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $152.00 to $152.68. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. F5: The stock option vested in equal monthly installments over 48 months commencing on April 23, 2017. --- Signature --- /s/ /s/ John G. Saia, as attorney-in-fact for AmirAli Talasaz (2026-06-30)

keid analysis is for reference only and does not constitute investment advice.